Buchumschlag

NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines

Tumor-infiltrating CD8 T cells were found to frequently express the inhibitory receptor NKG2A, particularly in immune-reactive environments and after therapeutic cancer vaccination. High dimensional cluster analysis demonstrated that NKG2A marks a unique immune effector subset preferentially co-expr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Montfoort, Nadine van (VerfasserIn) , Borst, Linda (VerfasserIn) , Korrer, Michael J. (VerfasserIn) , Sluijter, Marjolein (VerfasserIn) , Marijt, Koen A. (VerfasserIn) , Santegoets, Saskia J. (VerfasserIn) , van Ham, Vanessa J. (VerfasserIn) , Ehsan, Ilina (VerfasserIn) , Charoentong, Pornpimol (VerfasserIn) , André, Pascale (VerfasserIn) , Wagtmann, Nicolai (VerfasserIn) , Welters, Marij J.P. (VerfasserIn) , Kim, Young J. (VerfasserIn) , Piersma, Sytse J. (VerfasserIn) , van der Burg, Sjoerd H. (VerfasserIn) , van Hall, Thorbald (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018 Nov 29
In: Cell
Year: 2018, Jahrgang: 175, Heft: 7, Pages: 1744-1755.e15
ISSN:1097-4172
DOI:10.1016/j.cell.2018.10.028
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cell.2018.10.028
Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354585/
Volltext
Verfasserangaben:Nadine van Montfoort, Linda Borst, Michael J. Korrer, Marjolein Sluijter, Koen A. Marijt, Saskia J. Santegoets, Vanessa J. van Ham, Ilina Ehsan, Pornpimol Charoentong, Pascale André, Nicolai Wagtmann, Marij J.P. Welters, Young J. Kim, Sytse J. Piersma, Sjoerd H. van der Burg, and Thorbald van Hall
Beschreibung
Zusammenfassung:Tumor-infiltrating CD8 T cells were found to frequently express the inhibitory receptor NKG2A, particularly in immune-reactive environments and after therapeutic cancer vaccination. High dimensional cluster analysis demonstrated that NKG2A marks a unique immune effector subset preferentially co-expressing the tissue-resident CD103 molecule, but not immune checkpoint inhibitors. To examine if NKG2A represented an adaptive resistance mechanism to cancer vaccination, we blocked the receptor with an antibody and knocked out its ligand Qa-1b, the conserved ortholog of HLA-E, in four mouse tumor models. The impact of therapeutic vaccines was greatly potentiated by disruption of the NKG2A/Qa-1b axis, even in a PD-1 refractory mouse model. NKG2A blockade therapy operated through CD8 T cells, but not NK cells. These findings indicate that NKG2A-blocking antibodies might improve clinical responses to therapeutic cancer vaccines.,
Beschreibung:Gesehen am 19.03.2020
Beschreibung:Online Resource
ISSN:1097-4172
DOI:10.1016/j.cell.2018.10.028

Ähnliche Einträge